Cargando…

The Interaction of Amiodarone and Continuous-flow Left Ventricular Assist Device Use in Risk of Severe Primary Graft Dysfunction Following Heart Transplantation

BACKGROUND. Primary graft dysfunction (PGD) increases morbidity and mortality after heart transplant. Here we investigated (1) the association of continuous-flow left ventricular assist device (CF-LVAD), amiodarone, and severe PGD and (2) the safety of amiodarone discontinuation in CF-LVAD patients....

Descripción completa

Detalles Bibliográficos
Autores principales:	Chinnadurai, Thiru, Patel, Snehal R., Saeed, Omar, Hanif, Waqas, Rivas-Lasarte, Mercedes, Farooq, Muhammad, Castillo, Carolyne, Taveras, Maria, Fauvel, Daphenie, Shin, Jooyoung J., Sims, Daniel, Murthy, Sandhya, Vukelic, Sasha, Chavez, Patricia, Forest, Stephen, Goldstein, Daniel, Jorde, Ulrich P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Heart Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759622/ https://www.ncbi.nlm.nih.gov/pubmed/35047663 http://dx.doi.org/10.1097/TXD.0000000000001281

Ejemplares similares

Feasibility of high‐intensity interval training in patients with left ventricular assist devices: a pilot study
por: Alvarez Villela, Miguel, et al.
Publicado: (2020)

The Impact of Narrowing Perioperative Antibiotic Prophylaxis for Left-Ventricular-Assist Device Implantation
por: Allen, Lauren, et al.
Publicado: (2021)

Retrospective Evaluation of Rabbit Antithymocyte Globulin Induction in Heart Transplant Patients
por: Lee, Grace Pui-Yun, et al.
Publicado: (2022)

Analysis of Fibrotic Plaques in Angiographic Manifest Cardiac Allograft Vasculopathy in Long-term Heart Transplanted Patients Using Optical Coherence Tomography
por: Orban, Madeleine, et al.
Publicado: (2021)

Long-term Survival Following Heart Transplantation for Chagas Versus Non-Chagas Cardiomyopathy: A Single-center Experience in Northeastern Brazil Over 2 Decades
por: Vieira, Jefferson L., et al.
Publicado: (2022)

Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis
por: Guendouz, Soulef, et al.
Publicado: (2022)

Sex Related Differences in the Risk of Antibody-Mediated Rejection and Subsequent Allograft Vasculopathy Post-Heart Transplantation: A Single-Center Experience
por: Grupper, Avishay, et al.
Publicado: (2016)

Biomarkers to Assess Right Heart Pressures in Recipients of a Heart Transplant: A Proof-of-Concept Study
por: Huang, Qi-Fang, et al.
Publicado: (2018)

Simultaneous Versus Sequential Heart-liver Transplantation: Ideal Strategies for Organ Allocation
por: Rucker, A. Justin, et al.
Publicado: (2018)

Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients
por: Cehic, Matthew G., et al.
Publicado: (2019)

Disseminated Intravascular Coagulation Following Heart Transplant in an HIV-infected Recipient: Case Report and Review of the Literature
por: Zhou, Xun, et al.
Publicado: (2019)

Impact of Heart Transplantation on the Recovery of Peripheral and Respiratory Muscle Mass and Strength in Patients With Chronic Heart Failure
por: Fernandes, Lenise C. B. C., et al.
Publicado: (2018)

Reversibility of Frailty After Bridge-to-Transplant Ventricular Assist Device Implantation or Heart Transplantation
por: Jha, Sunita R., et al.
Publicado: (2017)

Access to Heart Transplantation: A Proper Analysis of the Competing Risks of Death and Transplantation Is Required to Optimize Graft Allocation
por: Cantrelle, Christelle, et al.
Publicado: (2017)

Three-Dimensional Self-Navigated T2 Mapping for the Detection of Acute Cellular Rejection After Orthotopic Heart Transplantation
por: van Heeswijk, Ruud B., et al.
Publicado: (2017)

Circulating Donor Heart Exosome Profiling Enables Noninvasive Detection of Antibody-mediated Rejection
por: Hu, Robert W., et al.
Publicado: (2020)

Rejection-associated Mitochondrial Impairment After Heart Transplantation
por: Romero, Erick, et al.
Publicado: (2020)

Low MicroRNA-126 Levels in Right Ventricular Endomyocardial Biopsies Coincide With Cardiac Allograft Vasculopathy in Heart Transplant Patients
por: Heggermont, Ward A., et al.
Publicado: (2020)

Heart Transplantation From Hepatitis C–Positive Donors in the Era of Direct Acting Antiviral Therapy: A Comprehensive Literature Review
por: Bruno, Schnegg, et al.
Publicado: (2019)

De Novo Belatacept in a Kidney-After-Heart Transplant Recipient
por: Schenk, Austin D., et al.
Publicado: (2019)

Bone Mineral Density in Relation to Chronic Kidney Disease After Heart Transplantation: A Retrospective Single-center Study at Skåne University Hospital in Lund 1988–2016
por: Löfdahl, Eveline, et al.
Publicado: (2020)

Impact of New UNOS Allocation Criteria on Heart Transplant Practices and Outcomes
por: Liu, Jason, et al.
Publicado: (2020)

Ex Situ Perfusion of Hearts Donated After Euthanasia: A Promising Contribution to Heart Transplantation
por: van Suylen, Vincent, et al.
Publicado: (2021)

Patient and Caregiver Health-related Quality of Life and Caregiver Burden While Awaiting Heart Transplantation: Findings From the Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support (SUSTAIN-IT) Study
por: Grady, Kathleen L., et al.
Publicado: (2021)

Differences in Heart Graft Survival by Recipient Sex
por: Foster, Bethany J., et al.
Publicado: (2021)

Trends in Heart and Lung Transplantation in the United States Across the COVID-19 Pandemic
por: Hallett, Andrew, et al.
Publicado: (2021)

Pulmonary Function Testing Pre–heart Transplant Predicts Posttransplant Survival
por: Lundgren, Scott W., et al.
Publicado: (2021)

Microvesicular Steatosis and Severe Cardiac Allograft Dysfunction
por: Mai, Xingchen, et al.
Publicado: (2022)

Clinical Outcomes of Perioperative Desensitization in Heart Transplant Recipients
por: Plazak, Michael E., et al.
Publicado: (2021)

Veno-arterial Extracorporeal Membrane Oxygenation as Bridge to Heart Transplantation: The Way Forward
por: Montisci, Andrea, et al.
Publicado: (2021)

Mitochondrial Damage-associated Molecular Patterns as Potential Biomarkers in DCD Heart Transplantation: Lessons From Myocardial Infarction and Cardiac Arrest
por: Longnus, Sarah L., et al.
Publicado: (2021)

Hemodynamic Response to Acute Volume Load and Endomyocardial NO-synthase Gene Expression in Heart Transplant Recipients
por: Kobediona, Monika, et al.
Publicado: (2022)

Value of Renal Histology in Predicting Cardiorenal Outcomes in Heart Transplant–listed Patients
por: Barua, Sumita, et al.
Publicado: (2022)

Ex Vivo Heart Perfusion for Cardiac Transplantation Allowing for Prolonged Perfusion Time and Extension of Distance Traveled for Procurement of Donor Hearts: An Initial Experience in the United States
por: Isath, Ameesh, et al.
Publicado: (2023)

Influence of Tricuspid Regurgitation After Heart Transplantation: A Single-center Experience
por: Krey, Rebecca, et al.
Publicado: (2023)

The Ability of Comorbidity Indices to Predict Mortality After Heart Transplantation: A Validation of the Danish Comorbidity Index for Acute Myocardial Infarction, Charlson Comorbidity Index, and Elixhauser Comorbidity Index
por: Bonnesen, Kasper, et al.
Publicado: (2023)

Coronary Collateral Circulation: A New Predictor of Mortality in Heart Transplant Recipients With Allograft Vasculopathy
por: Civieri, Giovanni, et al.
Publicado: (2023)

Recurrent Mild Acute Rejections and Donor-specific Antibodies as Risk Factors for Cardiac Allograft Vasculopathy in a National Pediatric Heart Transplant Cohort
por: Kaskinen, Anu K., et al.
Publicado: (2023)

Factors Associated With Sinoatrial Reinnervation After Heart Transplantation
por: Christensen, Anders H., et al.
Publicado: (2023)

Statin Use and In‐Hospital Mortality in Patients With Diabetes Mellitus and COVID‐19
por: Saeed, Omar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8rksps244chf5eikca603mrjpj